Business
Item 9 Labs Corp. Names Sara Gullickson as President
Item 9 Labs Corp. Names Sara Gullickson as President.
About this update from Item 9 Labs Corp.
[{"type":"text","content":"\nSCOTTSDALE, Ariz., July 02, 2018 (GLOBE NEWSWIRE) -- Item 9 Labs Corp. (OTC:INLB) (“Item 9 Labs”), a leading provider of cannabis health solutions for the modern consumer, announced that Sara Gullickson has been appointed as president of Item 9 Labs. Through the development of innovative lifestyle products and proprietary delivery platforms, Gullickson will oversee Item 9 Labs Licensing Application and Acquisition Strategy.\n Named one of the Top Ten Cannabis Entrepreneurs in the nation by Herb Magazine, Gullickson is an internationally recognized industry expert. Founder and CEO of Dispensary Permits, Gullickson brings over 8 years of experience in executive level roles. She will lead overall compliance, distribution and quality control for cultivation and production, and development of aggressive growth strategies with Bryce Skalla, CEO of Item 9 Labs. “I am delighted that Sara will lead Item 9 into its next stage of growth. She has been involved in the cannabis industry since its inception and has played an instrumental role in raising medical marijuana awareness.  As an established industry advocate, along with her past contributions and continued vision, we are confident that our expansion into the high-growth Cannabis Bio-Medical market will continue to be successful,” stated Skalla. Gullickson established her existing cannabis consulting firm Dispensary Permits in 2010, securing multiple cannabis license wins across 13 competitive state markets. Her operational and dispensary opening experience extends throughout North America, and includes consulting projects in Europe, South America, and New Zealand, regarding the implementation of new programs. “As the industry evolves many brands are becoming multi-market operators, its only a natural progression for our firm to represent both local entrepreneurs and national cannabis companies with applications and license acquisitions,” Gullickson noted. With Gullickson at the helm, Item 9 Labs will bring a balanced approach to a nuanced market, focusing on patients and wellness, “I’m thrilled to take on this leadership role and work closely with a company that aligns with my values and ethics. We both are dedicated to building quality and integrity within the cannabis community,” she announced. Gullickson’s market f...